Orientations

LC16m8 (live-attenuated freeze-dried vaccinia) smallpox and mpox vaccine - Interim Guidance

World Health Organization (WHO)

This first version of the interim guidance is primarily intended for use by health authorities, health workers, and other stakeholders involved in mpox vaccination and logistics for the deployment of the LC16m8 mpox vaccine in the Democratic Republic of the Congo (DRC) and other countries, as relevant.

Auteurs

Langues

Année de publication

2025

Type

Orientations

Catégories

Maladies

Pays

Organisations

Mots-clés

Régions de l'OMS

Mpox-Policy

Cette ressource apparaît sur le Thème suivant:

Cette ressource est incluse dans le tableau suivant:

TitreAuteurAnnéeTypeLangue
ETF statement on the use of Imvanex for the prevention of mpox in children below 12 years of ageEuropean Medicines Agency2024GuidanceAnglais
Frequently Asked Questions (FAQ) on use of fractional dosing with intradermal administration of mpox MVA-BN vaccine in the context of vaccine supply-constrained outbreak responseWorld Health Organization (WHO)2025GuidanceAnglais
LC16m8 (live-attenuated freeze-dried vaccinia) smallpox and mpox vaccine - Interim GuidanceWorld Health Organization (WHO)2025GuidanceAnglais, Français
MVA-BN (‎Modified Vaccinia Ankara – Bavarian Nordic)‎ smallpox and mpox vaccine: Interim guidanceWorld Health Organization (WHO)2024GuidanceAnglais, Français
Off-label vaccine use: explanatory note for countriesWorld Health Organization (WHO)2024GuidanceAnglais
Regulatory & Policy Considerations for Mpox Vaccines in African CountriesWorld Health Organization (WHO), European Medicines Agency, Bavarian Nordic2025PresentationAnglais
Smallpox and mpox (orthopoxviruses): WHO position paperWorld Health Organization (WHO)2024GuidanceAnglais, Français
Summary of WHO SAGE recommendations for mpox vaccines, including considerations for off-label useWorld Health Organization (WHO)2025PresentationAnglais
Log in to vote

Ajouté par: Miluka Gunaratna

Ajouté le: 2025-04-29 15:12:38

Consultations: 1737

Liens

Fichier téléchargé

Final_LC16m8_mpox_WHO_interim guidance_22April2025.pdf

Cliquez pour télécharger

Signaler un problème

Ajouter une ressource